MicroRNA 3913-1 (MIR3913-1)

MicroRNA 3913-1 is a short (~20-24 nucleotides), non-coding RNA molecule that belongs to the microRNA (miRNA) family, whose primary function is to regulate gene expression post-transcriptionally by binding to complementary mRNA sequences and inhibiting their translation or promoting their degradation[1]. MIR3913-1 is transcribed as part of a longer precursor RNA that is sequentially processed by Drosha and Dicer enzymes to yield the mature miRNA, which associates with the RNA-induced silencing complex (RISC) and guides it to target mRNAs via sequence complementarity[1][2]. While many microRNAs are implicated in cancer—acting either as tumor suppressors or as oncogenes (oncomirs)—the specific functional roles, target genes, and disease associations for MIR3913-1 remain to be fully elucidated, and there is no evidence that it is a direct therapeutic target or has known drug interactions at present[1][3][4]. The gene is cataloged by authoritative databases (HGNC:38884, NCBI Gene:100500903, Ensembl:ENSG00000264405, miRBase:hsa-mir-3913-1) which confirms proper nomenclature and usage[1].

Other names

hsa-mir-3913-1mir-3913-1MIR3913-1

Not applicable; microRNAs act via RNA-induced silencing complex (RISC) to regulate target gene expression by translational inhibition or mRNA degradation[1]